Fig. 3From: The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTsForest plot of the network meta-analysis of cardiovascular death, total death, hospitalization for heart failure, and renal outcome. DPP-4i: dipeptydil-peptidase-4 inhibitors; Pl: placebo; GLP-1RA: glucagon-like peptide-1 receptor agonists; SGLT-2i: sodium-glucose cotransporter-2 inhibitorsBack to article page